However, recent studies on bladder cancer have shown the immunosuppressive role of BCAT2 through its inhibitory impact on cytotoxic lymphocyte recruitment by restraining activities of proinflammatory cytokine/chemokine-related pathways and the T-cell chemotaxis pathway [41]. This evidence concerns the gene BCAT2 and urinary bladder cancer.